HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties

被引:3
作者
Giardino, Stefano [1 ,28 ]
Eikema, Dirk-Jan [2 ]
Piepenbroek, Brian [3 ]
Algeri, Mattia [4 ,5 ]
Ayas, Mouhab [6 ]
Faraci, Maura [1 ]
Tbakhi, Abdelghani [7 ]
Zecca, Marco [8 ]
Essa, Mohammed [9 ]
Neven, Benedicte [10 ]
Bertrand, Yves [11 ]
Kharya, Gaurav [12 ]
Bykova, Tatiana [13 ]
Lawson, Sarah [14 ]
Petrini, Mario [15 ]
Mohseny, Alexander [16 ]
Rialland, Fanny [17 ]
James, Beki [18 ]
Colita, Anca [19 ]
Fahd, Mony [20 ]
Cesaro, Simone [21 ]
Schulz, Ansgar [22 ]
Kleinschmidt, Katharina [23 ]
Kalwak, Krzysztof [24 ]
Corbacioglu, Selim [23 ]
Dufour, Carlo [25 ]
Risitano, Antonio [26 ]
de Latour, Regis Peffault [27 ]
机构
[1] IRCCS Ist Giannina Gaslini, Dept Pediat Hematol & Oncol, Hematopoiet Stem Cell Transplantat Unit, Genoa, Italy
[2] European Soc Blood & Marrow Transplantat EBMT, Stat Unit & Data Off, Leiden, Netherlands
[3] EBMT Leiden Study Unit, Leiden, Netherlands
[4] IRRCS Bambino Gesu Childrens Hosp, Dept Pediat Haematol & Oncol & Stem & Gene Therapy, Rome, Italy
[5] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
[6] King Faisal Specialist Hosp & Res Ctr, Dept Pediat Hematol Oncol, Riyadh, Saudi Arabia
[7] King Hussein Canc Ctr, Amman, Jordan
[8] Fdn IRCCS Policlin San Matteo, Pediat Hematol Oncol, Pavia, Italy
[9] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Specialist Childrens Hosp, King Abdullah Int Med Res Ctr, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[10] Necker Children Hosp, AP HP, Pediat Immune Hematol Unit, Paris, France
[11] Hosp Civil Lyon, Inst Hemato Oncol Pediat, Paris, France
[12] Indraprastha Apollo Hosp, Ctr Bone Marrow Transplant & Cellular Therapy, New Delhi, India
[13] Pavlov Univ, RM Gorbacheva Res Inst, St Petersburg, Russia
[14] Birmingham Childrens Hosp, Dept Haematol, Birmingham, England
[15] Univ Pisa, Santa Chiara Univ Hosp, Unit Hematol, Pisa, Italy
[16] Leiden Univ, Willem Alexander Childrens Hosp, Pediat SCT Program, Med Ctr, Leiden, Netherlands
[17] Hop Mere Enfant, Serv Chirurg Pediat, Nantes, France
[18] Leeds Childrens Hosp, Leeds Gen Infirm, Leeds, England
[19] Carol Davila Univ Med & Pharm, Fundeni Clin Inst, Bucharest, Romania
[20] GHU APHP Nord Univ Paris Cite, Hematol & Immunol Pediat Dept, Paris, France
[21] Azienda Osped Univ Integrata Verona, Dept Mother & Child, Pediat Hematol Oncol, Verona, Italy
[22] Univ Hosp Ulm, Dept Pediat Med, Eythstr 24, Ulm, Germany
[23] Univ Childrens Hosp Regensburg, Dept Pediat Hematol Oncol & Stem Cell Transplantat, Regensburg, Germany
[24] Wroclaw Med Univ, Suprareg Ctr Pediat Oncol Cape Hope, Wroclaw, Poland
[25] IRCCS Ist Giannina Gaslini, Dept Pediat Hematol & Oncol, Hematol Unit, Genoa, Italy
[26] Azienda Osped Rilievo Nazl San Giuseppe Moscati AO, Hematol & Hematopoiet Transplant Unit, Avellino, Italy
[27] Hop St Louis, AP HP, Bone Marrow Transplant Unit, Paris, France
[28] Ist Giannina Gaslini, Hematopoiet Stem Cell Transplantat Unit, Lgo Gaslini 5, I-16147 Genoa, GE, Italy
来源
CURRENT SCIENCE | 2024年 / 126卷 / 08期
关键词
VERSUS-HOST-DISEASE; POSTTRANSPLANT CYCLOPHOSPHAMIDE; FANCONI-ANEMIA; GRAFT FAILURE; ALPHA-BETA; B-CELLS; DEPLETION; BLOOD; ADOLESCENTS; OUTCOMES;
D O I
10.1002/ajh.27293
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Haploidentical stem cell transplantation (haplo-SCT) represents the main alternative for children with inherited bone marrow failure syndrome (I-BMF) lacking a matched donor. This retrospective study, conducted on behalf of the EBMT SAAWP and PDWP, aims to report the current outcomes of haplo-SCT in I-BMFs, comparing the different in vivo and ex vivo T-cell depletion approaches. One hundred and sixty-two I-BMF patients who underwent haplo-SCT (median age 7.4 years) have been registered. Fanconi Anemia was the most represented diagnosis (70.1%). Based on different T-cell depletion (TCD) approaches, four categories were identified: (1) TCR alpha beta(+)/CD19+-depletion (43.8%); (2) T-repleted with post-transplant Cyclophosphamide (PTCy, 34.0%); (3) In-vivo T-depletion with ATG/alemtuzumab (14.8%); (4) CD34(+) positive selection (7.4%). The cumulative incidences (CI) of neutrophil and platelet engraftment were 84% and 76% respectively, while that of primary and secondary graft failure was 10% and 8% respectively. The 100-day CI of acute GvHD grade III-IV(95% CI) was 13%, while the 24-month CI of extensive chronic GvHD was 4%. After a median follow-up of 43.4 months, the 2-year overall survival(OS) and GvHD/Rejection-free Survival (GRFS) probabilities are 67% and 53%, respectively. The TCR CD3(+)alpha beta(+)/CD19(+) depletion group showed a significantly lower incidence of both acute and chronic GvHD and higher OS (79%; p0.013) and GRFS (71%; p < .001), while no significant differences in outcomes have been observed by different diagnosis and conditioning regimens. This large retrospective study supports the safety and feasibility of haplo-SCT in I-BMF patients. TCR alpha beta(+)/CD19(+ )depletion offers higher chances of patients' survival, with a significantly lower risk of severe a- and c-GvHD in I-BMFs compared to other platforms.
引用
收藏
页码:1066 / 1076
页数:4
相关论文
共 56 条
[1]   Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up [J].
Alter, Blanche P. ;
Giri, Neelam ;
Savage, Sharon A. ;
Rosenberg, Philip S. .
HAEMATOLOGICA, 2018, 103 (01) :30-39
[2]   Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients [J].
Arnold, Danielle E. ;
MacMath, Derek ;
Seif, Alix E. ;
Heimall, Jennifer R. ;
Wang, Yongping ;
Monos, Dimitri ;
Grupp, Stephan A. ;
Bunin, Nancy J. .
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (02) :169.e1-169.e9
[3]  
Aversa Franco, 2007, Curr Stem Cell Res Ther, V2, P105, DOI 10.2174/157488807779316973
[4]   Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation [J].
Ayas, Mouhab ;
Siddiqui, Khawar ;
Al-Jefri, Abdullah ;
Al-Ahmari, Ali ;
Ghemlas, Ibrahim ;
Al-Saedi, Hawazen ;
Alanazi, Awatif ;
Jafri, Rafat ;
Ayas, Mohamad F. ;
Al-Seraihi, Amal .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) :2217-2221
[5]   Defining the Intensity of Conditioning Regimens: Working Definitions [J].
Bacigalupo, Andrea ;
Ballen, Karen ;
Rizzo, Doug ;
Giralt, Sergio ;
Lazarus, Hillard ;
Ho, Vincent ;
Apperley, Jane ;
Slavin, Shimon ;
Pasquini, Marcelo ;
Sandmaier, Brenda M. ;
Barrett, John ;
Blaise, Didier ;
Lowski, Robert ;
Horowitz, Mary .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) :1628-1633
[6]   Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes [J].
Balashov, Dmitry ;
Shcherbina, Anna ;
Maschan, Michael ;
Trakhtman, Pavel ;
Skvortsova, Yulia ;
Shelikhova, Larisa ;
Laberko, Alexandra ;
Livshits, Anna ;
Novichkova, Galina ;
Maschan, Alexei .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (11) :1955-1962
[7]   HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine [J].
Benajiba, Lina ;
Salvado, Clementine ;
Dalle, Jean-Hugues ;
Jubert, Charlotte ;
Galambrun, Claire ;
Soulier, Jean ;
Socie, Gerard ;
de Latour, Regis Peffault .
BLOOD, 2015, 125 (02) :417-418
[8]   HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders [J].
Bertaina, Alice ;
Merli, Pietro ;
Rutella, Sergio ;
Pagliara, Daria ;
Bernardo, Maria Ester ;
Masetti, Riccardo ;
Pende, Daniela ;
Falco, Michela ;
Handgretinger, Rupert ;
Moretta, Francesca ;
Lucarelli, Barbarella ;
Brescia, Letizia P. ;
Li Pira, Giuseppina ;
Testi, Manuela ;
Cancrini, Caterina ;
Kabbara, Nabil ;
Carsetti, Rita ;
Finocchi, Andrea ;
Moretta, Alessandro ;
Moretta, Lorenzo ;
Locatelli, Franco .
BLOOD, 2014, 124 (05) :822-826
[9]   A landscape of germ line mutations in a cohort of inherited bone marrow failure patients [J].
Bluteau, Olivier ;
Sebert, Marie ;
Leblanc, Thierry ;
de latour, Regis Peffault ;
Quentin, Samuel ;
Lainey, Elodie ;
Hernandez, Lucie ;
Dalle, Jean-Hugues ;
de Fontbrune, Flore Sicre ;
Lengline, Etienne ;
Itzykson, Raphael ;
Clappier, Emmanuelle ;
Boissel, Nicolas ;
Vasquez, Nadia ;
Da Costa, Melanie ;
Masliah-Planchon, Julien ;
Cuccuini, Wendy ;
Raimbault, Anna ;
De Jaegere, Louis ;
Ades, Lionel ;
Fenaux, Pierre ;
Maury, Sebastien ;
Schmitt, Claudine ;
Muller, Marc ;
Domenech, Carine ;
Blin, Nicolas ;
Bruno, Benedicte ;
Pellier, Isabelle ;
Hunault, Mathilde ;
Blanche, Stephane ;
Petit, Arnaud ;
Leverger, Guy ;
Michel, Gerard ;
Bertrand, Yves ;
Baruchel, Andre ;
Socie, Gerard ;
Soulier, Jean .
BLOOD, 2018, 131 (07) :717-732
[10]   Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia [J].
Bonfim, Carmem ;
Ribeiro, Lisandro ;
Nichele, Samantha ;
Loth, Gisele ;
Bitencourt, Marco ;
Koliski, Adriana ;
Kuwahara, Cilmara ;
Fabro, Ana Luiza ;
Pereira, Noemi F. ;
Pilonetto, Daniela ;
Thakar, Monica ;
Kiem, Hans-Peter ;
Page, Kristin ;
Fuchs, Ephraim J. ;
Eapen, Mary ;
Pasquini, Ricardo .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (02) :310-317